InvestorsHub Logo

jedijazz

09/21/22 11:40 AM

#1695 RE: ProfitScout #1677

$NMRD "Company sits at the intersection of the global Type 2 diabetes market that is expected to reach nearly $59 billion by 2025, the $50+ billion pre-diabetic market, and the wearable health-tech sector for weight loss and wellness applications that is estimated to reach $60 billion by 2023."

For more information, please visit www.NemauraMedical.com

In the Most recent news, CEO Dr. Faz Chowdhury presented a corporate overview at the 24th Annual H.C. Wainwright Global Investment Conference, which was held on September 12 – 14, 2022.



https://www.nasdaq.com/press-release/nemaura-medical-to-present-at-the-24th-annual-h.c.-wainwright-global-investment